Passar para o conteúdo principal

Conexão rápida

CPHI China 2024

Join us to discover how our API expertise can empower your business

June 19th - 21st, 2024
|
Shanghai New International Expo Center, China

Contact Us
Verified

Our Team at CPHI China 2024

About CPHI China 2024

CPHI & PMEC China is Asia's premier pharmaceutical event, bringing together suppliers and buyers across the entire pharmaceutical supply chain. Held in Shanghai at the Shanghai New International Expo Center, this in-person event unites the Chinese pharma community and fosters connections that drive innovation and industry growth.

Key highlights of CPHI China 2024:

  • Unrivalled networking opportunities: Connect with thousands of pharma professionals from across the globe.
  • Comprehensive exhibitor list: Discover a wide range of exhibitors across every sector of the Chinese pharmaceutical market.
  • Educational events: Gain insights from industry leaders through conferences and discussions.
  • Source cost-effective solutions: Find the latest advancements and solutions to optimise your business.

China 2024 is the ideal platform to expand business networks, discover new technologies, or find reliable partners.

 

About Dr.Reddy's API Business

We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 180+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom

About Graph

About Graph

Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.

ENQUIRE NOW

Sustainability

Dr. Reddy's is among the top sustainable pharmaceutical companies globally. We are listed in the sustainability yearbook of S&P 2022 for the second year in a row and the Bloomberg Gender-Equality Index (GEI) for the fifth consecutive year. In addition, we were ranked ninth in the Dow Jones Sustainability Index (DJSI) 2021 among the most sustainable pharmaceutical companies in the world. In our sustainability journey, these accolades are humbling and demonstrate that we're on the right track. These awards recognize our consistent performance in the environment, social, and governance (ESG) framework. Sustainability and ESG are becoming increasingly important topics for all stakeholders, so we will strive to maintain visibility in these areas.

Sustainability

Our Achievements

Our Plants

Dr. Reddy’s API  Manufacturing Locations

Company

© 2024 Dr. Reddy’s Laboratories Ltd. All rights reserved.

Aviso Legal

Nenhuma informação neste catálogo - incluindo qualquer referência a qualquer produto ou serviço - constitui uma oferta de venda ou deve ser interpretada como uma oferta de venda. Os produtos protegidos por patentes válidas não são oferecidos ou fornecidos para uso comercial. No entanto, as quantidades de pesquisa de tais produtos podem ser oferecidas para fins de submissão regulatória, onde quer que existam tais isenções regulatórias. Os compradores devem fazer sua avaliação independente do cenário de patentes para seus respectivos mercados e serão responsáveis por todas as responsabilidades relacionadas à patente. Os produtos protegidos por patentes válidas na Índia não estão disponíveis para uso comercial, mas estariam disponíveis para os propósitos da Seção 107A.